Stockreport

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market [Yahoo! Finance]

BioRestorative Therapies, Inc.  (BRTX) 
NASDAQ:AMEX Investor Relations: biorestorative.com/content/investor-relations
PDF the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has entered into definitive agreements with several accr [Read more]